IP Library Granted Patent US 11,427,612
Granted Patent B2
US 11,427,612 · App. 16/546,549 · Granted Aug 30, 2022

Epimerization-free N to C solid-phase peptide synthesis

Inventors: Jennifer L. Stockdill (West Bloomfield Township, MI); Christine A. Arbour (Cambridge, MA)
Assignee: Wayne State University
C07K1/042C07K1/023C07K1/084C07K1/10
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,427,612
App. No.
16/546,549
Granted
Aug 30, 2022
Kind
B2
Abstract

The present disclosure provides a method of solid-phase peptide synthesis from the N terminus to C terminus without detectable epimerization of the C-terminal amino acid. The method includes using derivatized amino acids comprising a diamino-aryl group.

Claims (20)

1. A method of synthesizing a peptide, wherein the method comprises preparing a first amino acid for synthesis, coupling an amino group of a second amino acid to the carboxyl group of the first amino acid to obtain a peptide, and optionally elongating the peptide by coupling one or more amino acids sequentially to a C-terminus of the peptide, wherein the amino acids used in the method are derivatized amino acids comprising a diamino-aryl group, and wherein the method proceeds without detectable epimerization of the second or sequentially coupled amino acid at the carboxyl terminus of the peptide.

2. The method of claim 1 , wherein the method comprises solid-phase peptide synthesis, solution phase peptide synthesis, or fluorous phase peptide synthesis.

3. The method of claim 1 , wherein the method comprises derivatizing amino acids by synthesizing amino acid diaminobenzoyl derivatives.

4. The method of claim 3 , wherein synthesis of amino acid diaminobenzoyl derivatives comprises obtaining Fmoc protected amino acid (Fmoc-AA-OH), reacting diaminobenzoylOMe (DbzOMe) with Fmoc-AA-OH to obtain Fmoc-AA-DbzOMe, and reacting with piperidine to remove Fmoc to yield H-AA-DbzOMe derivative.

5. The method of claim 1 , wherein synthesis of amino acid diamino-aryl derivatives comprises obtaining Fmoc protected amino acid (Fmoc-AA-OH), reacting diamino-aryl molecule with Fmoc-AA-OH to obtain Fmoc-AA-diamino-aryl molecule, and reacting with piperidine to remove Fmoc to yield H-AA-diamino aryl derivative.

6. The method of claim 1 , wherein preparing the first amino acid comprises attaching the first amino acid to a resin prior to coupling the amino group of the second amino acid to the carboxyl group of the first amino acid.

7. The method of claim 6 , wherein attaching the first amino acid to the resin comprises anchoring the α-amino group or a side-chain of the first amino acid to the resin.

8. The method of claim 7 , wherein the method further comprises activating the first amino acid to form a first amino acid comprising an N-acyl urea group.

9. The method of claim 8 , wherein activating the first amino acid comprises treating with 4-nitrophenyl chloroformate or other phosgene equivalent and followed by treating with Hünig's base.

10. The method of claim 9 , wherein coupling comprises adding a derivatized second amino acid to displace the N-acyl urea group on the first amino acid at its C terminus to yield a peptide.

11. The method of claim 10 , wherein the method further comprises elongation of the peptide comprising repetition of activation of the peptide and coupling of the peptide with another derivatized amino acid to obtain an N-acyl urea group terminated peptide.

12. The method of claim 11 , wherein the method further comprises after elongating the peptide to a desired length, cleaving the N-acyl urea group from the C-terminus of the peptide to obtain a C-terminally functionalized unprotected peptide or a C-terminally functionalized protected peptide.

13. The method of claim 12 , wherein cleaving the peptide comprises acidic resin cleavage to obtain a C-terminally functionalized unprotected peptide.

14. The method of claim 13 , wherein the acidic resin cleavage comprises treatment with trifluoroacetic acid (TFA) to cleave the peptide from the resin.

15. The method of claim 12 , wherein cleaving the peptide comprises nucleophilic resin cleavage to obtain a C-terminally functionalized protected peptide.

16. The method of claim 15 , wherein nucleophilic resin cleavage comprises treatment with one of the following nucleophiles: NH 3 , BuNH 2 , H 2 N(CH 2 ) 3 N 3 , propargylamine, aniline, H 2 NNH 2 , MeHNOMe, MeOH, EtOH, i-PrOH, BnOH, PhOH, H 2 O, or NaBH 4 .

17. The method of claim 11 , wherein unreacted derivatized amino acids are recovered and reused.

18. The method of claim 10 , wherein the method further comprises elongation of the peptide in the C to N direction.

19. The method of claim 18 , wherein elongation to the desired length is completed in the N to C direction.

20. The method of claim 1 , wherein the method proceeds without detectable epimerization of the second and sequentially coupled amino acid at the carboxyl terminus of the peptide.

Assignments (2)
CONFIRMATORY LICENSE Recorded Aug 2, 2022
From: WAYNE STATE UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 061047/0644 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 21, 2019
From: STOCKDILL, JENNIFER L.; ARBOUR, CHRISTINE A.
To: WAYNE STATE UNIVERSITY
Reel/Frame 050120/0576 →
Continuity (2)
Provisional Application 62720668 · Aug 21, 2018
Related Publication 20200062801A1 · Feb 27, 2020